{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06097364",
            "orgStudyIdInfo": {
                "id": "R1979-ONC-2075"
            },
            "secondaryIdInfos": [
                {
                    "id": "2022-502113-28-00",
                    "type": "OTHER",
                    "domain": "EUCT Number"
                }
            ],
            "organization": {
                "fullName": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma",
            "officialTitle": "A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)",
            "acronym": "OLYMPIA-2",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-trial-to-learn-if-odronextamab-combined-with-chemotherapy-is-safe-and-well-tolerated-and-how-well-it-works-compared-to-rituximab-combined-with-chemotherapy-for-adult-participants-with-follicular-lymphoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-14",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-07-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-07-29",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-18",
            "studyFirstSubmitQcDate": "2023-10-18",
            "studyFirstPostDateStruct": {
                "date": "2023-10-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Regeneron Pharmaceuticals",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin lymphoma or NHL. Participants with follicular lymphoma that has come back after treatment (called \"relapsed\") or did not respond to treatment (called \"refractory\") are eligible to take part only in Part 1A of the study.\n\nThis study is made up of 3 parts: Part 1A (non-randomized), Part 1B and Part 2 (randomized - controlled).\n\nThe aim of Part 1A and Part 1B of the study is to see how safe and tolerable the study drug in combination with chemotherapy is and to determine the dose and schedule of the study drug to be combined with chemotherapy to be used in Part 2 of the study.\n\nThe aim of Part 2 of the study is to assess how effective the combination of the study drug with chemotherapy is in comparison with the combination of rituximab and chemotherapy (the current standard-of-care for NHL). Standard-of-care means the usual medication expected and used when receiving treatment for a condition.\n\nThe study is looking at several other research questions, including:\n\n* What side effects may happen from taking the study drug\n* How much study drug is in the blood at different times\n* Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)\n* The impact from the study drug on quality-of-life and ability to complete routine daily activities"
        },
        "conditionsModule": {
            "conditions": [
                "Follicular Lymphoma (FL)"
            ],
            "keywords": [
                "Non-Hodgkin lymphomas (NHL)",
                "Relapsed or Refractory (R/R) FL",
                "B-cells NHL (B-NHL)",
                "Untreated FL",
                "Odronextamab"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 733,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Odronextamab + Chemotherapy",
                    "type": "EXPERIMENTAL",
                    "description": "Part 1 of the study includes ordonextamab dose escalation for participants with previously untreated FL and relapsed/refractory FL (Part 1A only) followed by a randomized exploration of 2 regimens of odronextamab (Odro) and cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) with the objective of dose optimization (Part 1B) in previously untreated patients with FL.",
                    "interventionNames": [
                        "Drug: Odronextamab",
                        "Drug: Cyclophosphamide",
                        "Drug: Doxorubicin",
                        "Drug: Prednisone/Prenisolone"
                    ]
                },
                {
                    "label": "Rituximab + Chemotherapy",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "In Part 2 only, participants will be randomized 1:1:1 to receive rituximab (R) with chemotherapy (CHOP), followed by rituximab monotherapy maintenance.",
                    "interventionNames": [
                        "Drug: Odronextamab",
                        "Drug: Rituximab",
                        "Drug: Cyclophosphamide",
                        "Drug: Doxorubicin",
                        "Drug: Vincristine",
                        "Drug: Prednisone/Prenisolone"
                    ]
                },
                {
                    "label": "Odronextamab + Chemotherapy + Maintenance",
                    "type": "EXPERIMENTAL",
                    "description": "In Part 2, participants will be randomized 1:1:1 to receive odronextamab with chemotherapy \\[CHOP, or cyclophosphamide, vincristine, and prednisone (CVP)\\], followed by odronextamab monotherapy maintenance.",
                    "interventionNames": [
                        "Drug: Odronextamab",
                        "Drug: Vincristine"
                    ]
                },
                {
                    "label": "Odronextamab + Chemotherapy + No maintenance",
                    "type": "EXPERIMENTAL",
                    "description": "In Part 2, participants will be randomized 1:1:1 to receive odronextamab with chemotherapy (CHOP, or CVP) without maintenance.",
                    "interventionNames": [
                        "Drug: Odronextamab",
                        "Drug: Vincristine"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Odronextamab",
                    "description": "Administered by intravenous (IV) infusion",
                    "armGroupLabels": [
                        "Odronextamab + Chemotherapy",
                        "Odronextamab + Chemotherapy + Maintenance",
                        "Odronextamab + Chemotherapy + No maintenance",
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "REGN1979"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Rituximab",
                    "description": "Administered by IV infusion, or subcutaneous (SC)",
                    "armGroupLabels": [
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "Rituxan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "Administered by IV infusion",
                    "armGroupLabels": [
                        "Odronextamab + Chemotherapy",
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "Cytoxan"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Doxorubicin",
                    "description": "Administered by IV infusion",
                    "armGroupLabels": [
                        "Odronextamab + Chemotherapy",
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "Adriamycin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Vincristine",
                    "description": "Administered by IV infusion",
                    "armGroupLabels": [
                        "Odronextamab + Chemotherapy + Maintenance",
                        "Odronextamab + Chemotherapy + No maintenance",
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "Oncovin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Prednisone/Prenisolone",
                    "description": "Administered orally (PO)",
                    "armGroupLabels": [
                        "Odronextamab + Chemotherapy",
                        "Rituximab + Chemotherapy"
                    ],
                    "otherNames": [
                        "Deltasone/Omnipred"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of dose limiting toxicities (DLTs) for odronextamab in combination with chemotherapy",
                    "description": "Part 1, DLT period",
                    "timeFrame": "Up to 35 days"
                },
                {
                    "measure": "Incidence of treatment-emergent adverse events (TEAEs) of odronextamab in combination with chemotherapy",
                    "description": "Part 1, Treatment period",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Severity of TEAEs of odronextamab in combination with chemotherapy",
                    "description": "Part 1, Treatment period",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Complete Response rate at 30 months (CR30) assessed by independent central review (ICR)",
                    "description": "Part 2",
                    "timeFrame": "Up to 30 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Odronextamab concentrations in serum when administered with chemotherapy",
                    "description": "Part 1, Maintenance period and Part 2, Induction period",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Odronextamab concentrations in serum when administered as monotherapy",
                    "description": "Part 1 and Part 2, Maintenance period",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Incidence of anti-odronextamab antibodies (ADAs)",
                    "description": "Part 1 and Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Titers of ADAs to odronextamab",
                    "description": "Part 1 and Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Incidence of neutralizing antibodies (NAb) to odronextamab",
                    "description": "Part 1 and Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Best overall response (BOR) as assessed by the investigator",
                    "description": "Part 1, end of Induction period and end of Maintenance period",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Progression free survival (PFS) as assessed by ICR",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "CR30 as assessed by local investigator",
                    "description": "Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Change in patient reported physical functioning scale scores on the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Cancer-30 (EORTC-QLQ-C30)",
                    "description": "Part 2 The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a global health status (GHS)/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties). For the functioning scales and global health status / QoL, scores range from 1 = \"very poor\" to 7 = \"excellent\" with higher scores indicate better functioning; for the symptom scales, scores range from 1 = \"not at all\" to 4 = \"very much\" higher scores indicate higher symptom burden.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "PFS as assessed by local investigator",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Event-free survival (EFS) as assessed by ICR",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "EFS as assessed by local investigator",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "BOR as assessed by local investigator",
                    "description": "Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "BOR as assessed by ICR",
                    "description": "Part 2",
                    "timeFrame": "Up to 30 months"
                },
                {
                    "measure": "Duration of response (DOR) assessed by ICR",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "DOR as assessed by local investigator",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Time to next anti-lymphoma treatment (TTNT)",
                    "description": "Part 2",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Incidence of TEAEs",
                    "description": "Part 2",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Severity of TEAEs",
                    "description": "Part 2",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Change in patient reported health related quality of life (HRQoL) as measured by EORTC-QLQ-C30",
                    "description": "Part 2 The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a GHS/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties). For the functioning scales and global health status / QoL, scores range from 1 = \"very poor\" to 7 = \"excellent\" with higher scores indicate better functioning; for the symptom scales, scores range from 1 = \"not at all\" to 4 = \"very much\" higher scores indicate higher symptom burden.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in cancer disease as measured by EORTC-QLQ-C30",
                    "description": "Part 2 The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a GHS/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties). For the functioning scales and global health status / QoL, scores range from 1 = \"very poor\" to 7 = \"excellent\" with higher scores indicate better functioning; for the symptom scales, scores range from 1 = \"not at all\" to 4 = \"very much\" higher scores indicate higher symptom burden.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in treatment related symptoms as measured by EORTC-QLQ-C30",
                    "description": "Part 2 The EORTC QLQ-C30 includes 5 functional scales (physical, role, cognitive, emotional and social functioning), 3 symptom scales (fatigue, pain and nausea/vomiting), a GHS/QoL scale, and six single items (constipation, diarrhea, insomnia, shortness of breath, appetite loss and financial difficulties). For the functioning scales and global health status / QoL, scores range from 1 = \"very poor\" to 7 = \"excellent\" with higher scores indicate better functioning; for the symptom scales, scores range from 1 = \"not at all\" to 4 = \"very much\" higher scores indicate higher symptom burden.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in patient-reported lymphoma disease as measured by the Lymphoma Subscale of the Functional Assessment of Cancer Treatment-Lymphoma (FACT-LymS)",
                    "description": "Part 2 The FACT-Lym lymphoma subscale (LymS) includes 15 items to assess NHL-related symptoms and concerns. All questions are answered on a 5-point scale ranging from \"not at all\" (0) to \"very much\" (4). Higher scores are associated with a worse quality of life.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in treatment-related symptoms as measured by the FACT-LymS",
                    "description": "Part 2 The FACT-LymS includes 15 items to assess NHL-related symptoms and concerns. All questions are answered on a 5-point scale ranging from \"not at all\" (0) to \"very much\" (4). Higher scores are associated with a worse quality of life.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in patient-reported general health status per EuroQol-5 Dimensions-5 Levels (EQ-5D-5L)",
                    "description": "Part 2 The EQ-5D-5L consists of the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The EQ-5D-5L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: \"no problems\", \"slight problems\", \"moderate problems\", \"severe problems\" and \"extreme problems\". The EQ VAS records the participant's self-rated health on a vertical visual analogue scale where the endpoints are labeled \"Best imaginable health state\" and \"Worst imaginable health state\".",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in patient-reported treatment side effects burden per Functional Assessment of Cancer Therapy-General Global Population Item 5 (FACT-G GP5)",
                    "description": "Part 2 A single item GP5 of the validated FACT-G questionnaire will be used to assess from the participant perspective the overall impact of treatment side-effect. The question item is on a 5-point scale ranging from \"not at all\" (0) to \"very much\" (4).",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in Patient Global Impression of Severity (PGIS)",
                    "description": "Part 2 The PGIS includes a single-item to assess how a patient perceives the overall severity of cancer symptoms over the past 7 days. Patients will choose the response that best describes the severity of their overall cancer symptoms with options on a 5-point scale ranging from 1 (No symptoms) to 4 (Very Severe).",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in Patient Global Impression of Change (PGIC)",
                    "description": "Part 2 The PGIC item includes a single-item to assess how a patient perceives their overall change in health status since the start of study treatment. Patients will choose from response options on a 7-point scale ranging from 1 (Much Better) to 7 (Much worse); 1- Much Better, 2-Moderately Better, 3-A Little Better, 4-About the Same, 5-A Little Worse, 6-Moderately Worse, 7-Much Worse.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Change in score of the FACT-G GP5 item in the patient population",
                    "description": "Part 2 A single item GP5 of the validated FACT-G questionnaire will be used to assess from the participant perspective the overall impact of treatment side-effect. The question item is on a 5-point scale ranging from \"not at all\" (0) to \"very much\" (4).",
                    "timeFrame": "Up to 5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n1. Have diagnosis of cluster of differentiation 20 positive (CD20+) FL grade 1-3a, stage II bulky or stage III / IV\n\n   1. For Part 1A: previously untreated participants who have Follicular Lymphoma International Prognostic Index (FLIPI)-1 score of 3 to 5, or R/R FL\n   2. For Part 1B: previously untreated participants who have FLIPI-1 score of 3 to 5\n   3. For Part 2: previously untreated participants who have FLIPI-1 score of 0 to 5\n2. Have measurable disease on cross sectional imaging documented by diagnostic computed tomography \\[CT\\], or magnetic resonance imaging \\[MRI\\] imaging, as described in the protocol\n3. Eastern Cooperative Oncology Group (ECOG) performance status of 0-2\n4. Adequate bone marrow and hepatic function.\n\nKey Exclusion Criteria:\n\n1. Participants with central nervous system lymphoma or leptomeningeal lymphoma\n2. Participants with histological evidence of transformation to a high-grade or diffuse large B-cell lymphoma\n3. Participants with Waldenstr\u00f6m macroglobulinemia (WM, lymphoplasmacytic lymphoma), grade 3b follicular lymphoma, chronic lymphocytic leukemia or small lymphocytic lymphoma\n4. Recent major surgery and history or organ transplantation\n5. A malignancy other than NHL unless the participant is adequately and definitively treated and any other significant active disease or medical condition that could interfere with the conduct of the study or put the participant at significant risk, as described in the protocol.\n\nNote: Other protocol-defined Inclusion/Exclusion criteria apply",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Clinical Trials Administrator",
                    "role": "CONTACT",
                    "phone": "844-734-6643",
                    "email": "clinicaltrials@regeneron.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trial Management",
                    "affiliation": "Regeneron Pharmaceuticals",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Investigative Clinical Research of Indiana",
                    "status": "RECRUITING",
                    "city": "Noblesville",
                    "state": "Indiana",
                    "zip": "46062",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ruemu Birhiray",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.04559,
                        "lon": -86.0086
                    }
                },
                {
                    "facility": "University of Kentucky",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40536",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chaitanya Iragavarapu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "Henry Ford Hospital",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jawad Sheqwara",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Cancer and Hematology Centers of Western Michigan",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49503",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Colin Hardin",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Clinical Research Alliance, Inc.",
                    "status": "RECRUITING",
                    "city": "Westbury",
                    "state": "New York",
                    "zip": "11590",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James D'Olimpio",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.75566,
                        "lon": -73.58763
                    }
                },
                {
                    "facility": "Center for Oncology and Blood Disorders",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Luis Camacho",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Community Cancer Trials of Utah",
                    "status": "RECRUITING",
                    "city": "Ogden",
                    "state": "Utah",
                    "zip": "84405",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carl Gray",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.223,
                        "lon": -111.97383
                    }
                },
                {
                    "facility": "ProHealth Care Inc",
                    "status": "RECRUITING",
                    "city": "Waukesha",
                    "state": "Wisconsin",
                    "zip": "53188",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Timothy Wassenaar",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.01168,
                        "lon": -88.23148
                    }
                },
                {
                    "facility": "Calvary Mater Newcastle",
                    "status": "RECRUITING",
                    "city": "Waratah",
                    "state": "New South Wales",
                    "zip": "2298",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Aung Thant",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -32.90667,
                        "lon": 151.72647
                    }
                },
                {
                    "facility": "Pindara Private Hospital",
                    "status": "RECRUITING",
                    "city": "Benowa",
                    "state": "Queensland",
                    "zip": "4217",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Hanlon Sia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -28.01667,
                        "lon": 153.4
                    }
                },
                {
                    "facility": "University Hospital Ghent",
                    "status": "RECRUITING",
                    "city": "Ghent",
                    "state": "East Flanders",
                    "zip": "9000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Ciel De Vriendt",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "Vzw - Vitaz",
                    "status": "RECRUITING",
                    "city": "Sint-Niklaas",
                    "state": "East Flanders",
                    "zip": "9100",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Vanessa Van Hende",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.16509,
                        "lon": 4.1437
                    }
                },
                {
                    "facility": "CHR Verviers",
                    "status": "RECRUITING",
                    "city": "Verviers",
                    "state": "Liege",
                    "zip": "4000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Selim Sid",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.58907,
                        "lon": 5.86241
                    }
                },
                {
                    "facility": "AZ Groeninge",
                    "status": "RECRUITING",
                    "city": "Kortrijk",
                    "state": "West Flanders",
                    "zip": "8500",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Koenraad Van Eygen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.82803,
                        "lon": 3.26487
                    }
                },
                {
                    "facility": "Hopital Universitaire de Bruxelles - Site Bordet",
                    "status": "RECRUITING",
                    "city": "Brussels",
                    "zip": "1000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Fulvio Massaro",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.85045,
                        "lon": 4.34878
                    }
                },
                {
                    "facility": "Pontificia Universidad Catolica de Chile",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region Metropolitana",
                    "zip": "7550000",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "James Campell",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Immunocel",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Santiago Metropolitan Region",
                    "zip": "7580206",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Alejandro Berkovitz Caceres",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Clinica Universidad de los Andes",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "zip": "7620157",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Cristian Carvallo",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Hadassah Medical Center",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "state": "Jersualem",
                    "zip": "91220",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Neta Goldschmidt",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Rabin Medical Center",
                    "status": "RECRUITING",
                    "city": "Petah Tikva",
                    "zip": "49100",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Ronit Gurion",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08707,
                        "lon": 34.88747
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "zip": "64239",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Irit Avivi",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Universita degli Studi di Napoli Federico II",
                    "status": "RECRUITING",
                    "city": "Naples",
                    "state": "Campania",
                    "zip": "80128",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Fabrizio Pane",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Azienda Unita Sanitaria Locale",
                    "status": "RECRUITING",
                    "city": "Ravenna",
                    "state": "Emilia-Romagna",
                    "zip": "48121",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Monica Tani",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.41344,
                        "lon": 12.20121
                    }
                },
                {
                    "facility": "Instituto Scientifico Romagnolo",
                    "status": "RECRUITING",
                    "city": "Meldola",
                    "state": "Forli-Cesena",
                    "zip": "47014",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Gerardo Musuraca",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.12775,
                        "lon": 12.0626
                    }
                },
                {
                    "facility": "IEO Istituo Europeo di Oncologia",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20141",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Enrico Derenzini",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Azienda Sanitaria Universitaria del Friuli Centrale",
                    "status": "RECRUITING",
                    "city": "Udine",
                    "zip": "33100",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Jacopo Oliveri",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 46.0693,
                        "lon": 13.23715
                    }
                },
                {
                    "facility": "Malopolskie Centrum Medyczne SC",
                    "status": "RECRUITING",
                    "city": "Krakow",
                    "state": "Malopolskie",
                    "zip": "30-510",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Wojciech Jurczak",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.06143,
                        "lon": 19.93658
                    }
                },
                {
                    "facility": "Pratia Onkologia Katowice",
                    "status": "RECRUITING",
                    "city": "Katowice",
                    "state": "Silesia",
                    "zip": "40-519",
                    "country": "Poland",
                    "contacts": [
                        {
                            "name": "Sebastian Grosicki",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.25841,
                        "lon": 19.02754
                    }
                },
                {
                    "facility": "Hospital Universitario Central de Asturias",
                    "status": "RECRUITING",
                    "city": "Oviedo",
                    "state": "Asturas",
                    "zip": "33011",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Angel Ramirez Payer",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.36029,
                        "lon": -5.84476
                    }
                },
                {
                    "facility": "Consorci Corporacio Sanitaria Parc Tauli",
                    "status": "RECRUITING",
                    "city": "Sabadell",
                    "state": "Barcelona",
                    "zip": "08290",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Juan Alfonso Soler Campos",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.54329,
                        "lon": 2.10942
                    }
                },
                {
                    "facility": "Hospital Universitario Puerta de Hierro Majadahonda",
                    "status": "RECRUITING",
                    "city": "Majadahonda",
                    "state": "Madrid",
                    "zip": "28222",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Mariano Provencio Pulla",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.47353,
                        "lon": -3.87182
                    }
                },
                {
                    "facility": "Clinica Universidad de Navarra - Sede Pamplona",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "state": "Navarre",
                    "zip": "31008",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Carlos Grande",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Clinica Universidad de Navarra - Sede Madrid",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28027",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Carlos Grande Garcia",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Infanta Leonor",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28031",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Jose-Angel Hernandez-Rivas",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Ramon y Cajal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Francisco Javier Lopez Jimenez",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Fundacion Jimenez Diaz",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Raul Cordoba",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Ana Jimenez Ubieto",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Quironsalud Madrid",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28223",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Maria Aranzazu Alonso Alonso",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario de Salamanca",
                    "status": "RECRUITING",
                    "city": "Salamanca",
                    "zip": "37007",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Alejandro Martin Garcia-Sancho",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.96882,
                        "lon": -5.66388
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen del Rocio",
                    "status": "RECRUITING",
                    "city": "Sevilla",
                    "zip": "41013",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Fatima de la Cruz Vicente",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Hospital Universitari Mutua Terrassa",
                    "status": "RECRUITING",
                    "city": "Terrassa",
                    "zip": "08221",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Ana Muntanola Prat",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.56667,
                        "lon": 2.01667
                    }
                },
                {
                    "facility": "Hospital Universitario de Toledo",
                    "status": "RECRUITING",
                    "city": "Toledo",
                    "zip": "45007",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Luis Felipe Casado Montero",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.8581,
                        "lon": -4.02263
                    }
                },
                {
                    "facility": "Instituto Valenciano de Oncologia",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46009",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Marcos Melian Sosa",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Taipei Medical University Shuang Ho Hospital",
                    "status": "RECRUITING",
                    "city": "New Taipei City",
                    "state": "New Taipei",
                    "zip": "23561",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Tsu Yi Chao",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.01111,
                        "lon": 121.44583
                    }
                },
                {
                    "facility": "Kaohsiung Medical University Hospital",
                    "status": "RECRUITING",
                    "city": "Kaohsiung",
                    "zip": "80756",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Shih-Feng Cho",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Tri-Service General Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "zip": "11490",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Yeu Chin Chen",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Taipei Municipal Wan Fang Hospital",
                    "status": "RECRUITING",
                    "city": "Taipei",
                    "zip": "11696",
                    "country": "Taiwan",
                    "contacts": [
                        {
                            "name": "Tzeon-Jye Chiou",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                },
                {
                    "facility": "Chulalongkorn University",
                    "status": "RECRUITING",
                    "city": "Bangkok",
                    "zip": "10330",
                    "country": "Thailand",
                    "contacts": [
                        {
                            "name": "Kitsada Wudhikarn",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 13.75398,
                        "lon": 100.50144
                    }
                },
                {
                    "facility": "Srinagrind Hospital",
                    "status": "RECRUITING",
                    "city": "Khon Kaen",
                    "zip": "40000",
                    "country": "Thailand",
                    "contacts": [
                        {
                            "name": "Chinadol Wanitpongpun",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 16.44671,
                        "lon": 102.833
                    }
                },
                {
                    "facility": "Sakayra University Training and Research Hospital",
                    "status": "RECRUITING",
                    "city": "Adapazari",
                    "state": "Sakarya",
                    "zip": "54290",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Tuba Hacibekiroglu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.78056,
                        "lon": 30.40333
                    }
                },
                {
                    "facility": "Gazi University",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Munci Yagci",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital",
                    "status": "RECRUITING",
                    "city": "Ankara",
                    "zip": "06200",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Fevzi Altuntas",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.91987,
                        "lon": 32.85427
                    }
                },
                {
                    "facility": "Istanbul University",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34093",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Mustafa Yenerel",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "VKV American Hospital",
                    "status": "RECRUITING",
                    "city": "Istanbul",
                    "zip": "34365",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Ahmet Ferhanoglu",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.01384,
                        "lon": 28.94966
                    }
                },
                {
                    "facility": "Erciyes University",
                    "status": "RECRUITING",
                    "city": "Kayseri",
                    "zip": "38030",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Ali Unal",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.73222,
                        "lon": 35.48528
                    }
                },
                {
                    "facility": "Tekirdag Namik Kemal University Hospital",
                    "status": "RECRUITING",
                    "city": "Tekirdag",
                    "zip": "59100",
                    "country": "Turkey",
                    "contacts": [
                        {
                            "name": "Burhan Turgut",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.9781,
                        "lon": 27.51101
                    }
                },
                {
                    "facility": "Aberdeen Royal Infirmary",
                    "status": "RECRUITING",
                    "city": "Aberdeen",
                    "state": "Aberdeenshire",
                    "zip": "AB25 2ZN",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Gavin Preston",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 57.14369,
                        "lon": -2.09814
                    }
                },
                {
                    "facility": "Royal Cornwall Hospital NHS Trust",
                    "status": "RECRUITING",
                    "city": "Truro",
                    "state": "Cornwall",
                    "zip": "TR1 3LJ",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "David Tucker",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.26526,
                        "lon": -5.05436
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "All Individual Patient Data (IPD) that underlie publicly available results will be considered for sharing",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "CSR",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "When Regeneron has received marketing authorization from major health authorities (e.g., FDA, European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA), etc.) for the product and indication, has made the study results publicly available (e.g., scientific publication, scientific conference, clinical trial registry), has the legal authority to share the data, and has ensured the ability to protect participant privacy.",
            "accessCriteria": "Qualified researchers can submit a proposal for access to individual patient or aggregate level data from a Regeneron-sponsored clinical trial through Vivli. Regeneron's Independent Research Request Evaluation Criteria can be found at: https://www.regeneron.com/sites/default/files/Regeneron-External-Data-Sharing-Policy-and-Independent-Research-Request-Evaluation-Criteria.pdf",
            "url": "https://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000008224",
                    "term": "Lymphoma, Follicular"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000008228",
                    "term": "Lymphoma, Non-Hodgkin"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11221",
                    "name": "Lymphoma, Follicular",
                    "asFound": "Follicular lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11222",
                    "name": "Lymphoma, Non-Hodgkin",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2361",
                    "name": "Follicular Lymphoma",
                    "asFound": "Follicular lymphoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011241",
                    "term": "Prednisone"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000069283",
                    "term": "Rituximab"
                },
                {
                    "id": "D000004317",
                    "term": "Doxorubicin"
                },
                {
                    "id": "D000014750",
                    "term": "Vincristine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000903",
                    "term": "Antibiotics, Antineoplastic"
                },
                {
                    "id": "D000059005",
                    "term": "Topoisomerase II Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7492",
                    "name": "Doxorubicin",
                    "asFound": "Cognitive",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17495",
                    "name": "Vincristine",
                    "asFound": "Phase I",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M14121",
                    "name": "Prednisone",
                    "asFound": "Prospective",
                    "relevance": "HIGH"
                },
                {
                    "id": "M373",
                    "name": "Rituximab",
                    "asFound": "Infusion",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11749",
                    "name": "Methylprednisolone",
                    "relevance": "LOW"
                },
                {
                    "id": "M1833",
                    "name": "Methylprednisolone Acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M11750",
                    "name": "Methylprednisolone Hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M14120",
                    "name": "Prednisolone",
                    "relevance": "LOW"
                },
                {
                    "id": "M229449",
                    "name": "Prednisolone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M211887",
                    "name": "Prednisolone hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M248881",
                    "name": "Prednisolone phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M20194",
                    "name": "Antibodies, Bispecific",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M227339",
                    "name": "Liposomal doxorubicin",
                    "relevance": "LOW"
                },
                {
                    "id": "M19201",
                    "name": "Muromonab-CD3",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "NeuroAg",
                    "name": "Neuroprotective Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}